Description
Composition- Cefpodoxime 200 mg + Clavulanic Acid 125 mg
Mode of Action- Combines third-generation cephalosporin action with β-lactamase inhibition, enhancing antibacterial activity against resistant organisms.
USPs- Broad-spectrum coverage; effective in resistant infections; improved clinical success rate.
Prescribing Specialties- Physician, ENT Specialist, Pediatrician
